LIFECORE BIOMEDICAL, INC. DE - Common Stock, $0.001 par value (LFCR)

CUSIP: 514766104

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+308,862
Put/Call ratio
72%
SEC-reported price per share
$5.31
Number of holders
75
Value change
+$1,281,084
Number of buys
36
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,546,923

Security key

514766104

Report period

Q1 2024

Institutions

75

Top holders

10

Ownership snapshot

Top reported holders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WYNNEFIELD CAPITAL INC
Disclosed value leader
WYNNEFIELD CAPITAL INC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $30,476,744 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WYNNEFIELD CAPITAL INC has the largest disclosed position value at $30.48M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WYNNEFIELD CAPITAL INC's linked filing trail.
Disclosed position value Top 5
WYNNEFIELD CAPITAL INC $30.48M
Legion Partners Asset Management,... $18.2M
Greenhaven Road Investment Manage... $14.65M
22NW, LP $10.86M
VANGUARD GROUP INC $8.36M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WYNNEFIELD CAPITAL INC
13F
Company
13F
—
denominator unverified
$30,476,744
4,923,545 shares
— 31 Dec 2023
Legion Partners Asset Management, LLC
13F
Company
13F
—
denominator unverified
$18,200,705
2,940,340 shares
— 31 Dec 2023
Greenhaven Road Investment Management, L.P.
13F
Company
13F
—
denominator unverified
$14,651,458
2,366,956 shares
— 31 Dec 2023
22NW, LP
13F
Company
13F
—
denominator unverified
$10,864,447
1,755,161 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$8,360,009
1,350,567 shares
— 31 Dec 2023
325 CAPITAL LLC
13F
Company
13F
—
denominator unverified
$7,471,138
1,206,969 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
75
Shares
21,527,122
Rows available
75
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
75
Q1 2024 holders
75
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .